中东和非洲疫苗接种设备市场 – 行业趋势和 2030 年预测

中东和非洲疫苗接种设备市场分析和规模

增加免疫计划和活动以及开发新型疫苗是推动 2023-2030 年预测期内市场需求的主要驱动力。预计有效提供疫苗的几项技术进步将推动市场增长。全球生物技术、制药公司和政府正在努力制定疫苗交付供应链挑战的战略并开发有效的疫苗。  

Data Bridge Market Research 分析了 2023-2030 年预测期内疫苗接种设备市场的增长率。在上述预测期内，疫苗接种设备市场的预期复合年增长率趋于 4.40% 左右。2022 年市场价值为 1.0045 亿美元，到 2030 年将增长至 1.4176 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

中东和非洲疫苗接种设备市场范围和细分

Market Definition

Vaccines are known as a set of biological preparations that protect humans from viruses and other bacteria-related infections. Some are inactivated/killed vaccines, live/attenuated vaccines, toxoid vaccines, and conjugate vaccines. Vaccines are administered intramuscularly or subcutaneously using a syringe or needle. Furthermore, needle-free technologies are the unique vaccine administration technologies as they are highly effective in mass immunization programs, reducing the risk of needle stick injuries and the consequences of many needles use.  

Middle East and Africa Vaccine Administration Devices Market Dynamics

Drivers

• Growing Demand for Intradermal Vaccination

The intradermal route of administration has attracted much attention in the past few years because of benefits such as improved safety, dose sparing, and improved access to vaccines. These factors are anticipated to lead to market growth over the following years. Additionally, a rise in the studies of alternative methods for intradermal administration with several novel devices, such as jet injectors and microneedles, is expected to enhance market growth.

• Increasing Number of Immunization Programs

The increasing number of immunization programs and the wide availability of syringes is anticipated to play a major role in the market's growth. For instance, with the ongoing large-scale vaccination programs in this region, syringes are being used widely in delivering vaccines; therefore, the production of syringes has increased significantly. For instance, Hindustan Syringes & Medical Devices Ltd (H.M.D.) received orders from the Indian government to supply 256 million auto-disposable needles in 2021, earlier H.M.D. had received an order of 177.5 million 0.5 mL auto-disposable syringes from the Indian government during COVID-19 pandemic. Thus, this boosts market growth.

Opportunities

• Increasing Rate of Product Launches

An increasing number of product launches associated with vaccines help surge market growth. For instance, vaccines developed by the Serum Institute of India acquired a 50% share in a pharma packing firm, Schott Kaisha, in 2021. This initiative positions the Serum Institute of India in a joint venture with Schott AG, which is a specialty glass company based in Germany. Moreover, numerous initiatives by government agencies to develop new vaccines offer opportunities for growth in the market. Thus, this factor increases the market growth.

• Increasing Healthcare Expenditure from Different Organizations

Immunization coverage is increasing with financial support from international organizations such as Bill & Melinda Gates Foundation, GAVI Alliance, and Path. More vaccines, including those for life-threatening diseases, are increasingly accessible to the population. In underdeveloped and developing nations, innovative funding mechanisms are applied to increase vaccination coverage and provide new vaccines. Furthermore, Global Alliance for Vaccines and Immunizations (GAVI) extended its support in June 2017. This will make the vaccine available to millions of children through the routine immunization program to eliminate polio. Thus, this factor increases the growth of the market.  

Restraints/Challenges

• Side-Effects of Vaccine Administration Devices

Numerous side effects associated with vaccine administration devices limit the market growth. Effects such as redness and soreness at the injection site or fever and allergic reactions are the primary effects. Additionally, needle-free injections have a huge drawback with clinical concerns. The high-pressure delivery of drugs can damage fragile molecules under the skin layer, mainly in administering monoclonal antibodies. All these factors hamper the growth of the market.

This vaccine administration devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaccine administration devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2021, Midas Pharma and Gerresheimer formed a strategic partnership for developing and marketing the new-generation autoinjector. The go-to-market approach for the auto-injector combines the strengths of both companies- Gerresheimer as a solution provider for medical devices and primary packaging solutions and Midas Pharma as an experienced facilitator for global pharma projects and provider of products and services along the pharmaceutical value chain.

Middle East and Africa Vaccine Administration Devices Market Scope

The vaccine administration devices market is segmented on the basis of product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Syringes
• Auto Injectors
• Jet Injectors
• Micro Needles
• Inhalation/Pulmonary Delivery
• Microinjection System
• Pen Injector Devices
• Biodegradable Implants
• Electroporation-Based Needle Free Injection Systems
• Buccal /Sublingual Vaccine Delivery Systems
• Autoinjector Trainer Devices
• Others Devices

Route of Administration

• Intramuscular
• Subcutaneous
• Intradermal

Type

• Marketed Vaccines
• Clinical-Stage Vaccines (Electroporation)

Brand

• BD Accuspray Nasal Spray System
• BD Hypak for Vaccines Glass Pre-Fillable Syringe System
• BD Uniject Auto-Disable Pre-Fillable Injection System
• Gx InnoSafe
• Gx RTF ClearJect, Plajex
• Others

Dosage

• Fixed
• Variable

Vaccine Type

• Bivalent Oral PolioVaccine
• B.C.G. Vaccine
• Tetanus-Diphtheria Vaccine
• DTP-HEPB-HIB Vaccine
• Influenza Vaccine
• Pneumococcal Conjugate Vaccine
• Measles Vaccine
• Others

Modality

• 自动疫苗接种装置
• 手动疫苗注射装置

可用性

• 一次性的
• 可重复使用的

最终用户

• 医院
• 社区中心
• 家庭护理环境
• 研究与学术机构
• 门诊手术中心
• 其他的

 分销渠道

• 直接招标
• 零售销售

疫苗接种设备市场区域分析/见解

对疫苗接种设备市场进行了分析，并按上述产品、接种途径、类型、品牌、剂量、疫苗类型、方式、可用性、最终用户和分销渠道提供了市场规模洞察和趋势。

疫苗接种设备市场报告涉及的主要国家 是沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲（MEA）的其他地区（中东和非洲（MEA）的一部分）

由于患者人数众多、目标人群不断增加、未满足的需求很高以及该地区的基础设施不断改善，预计沙特阿拉伯将在预测期内实现最快的增长率。此外，不健康的生活方式和易患传染病的老年人口增加导致疾病发病率上升。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内市场监管变化。此外，在提供国家数据预测分析的同时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

竞争格局和中东和非洲疫苗接种设备市场份额分析

疫苗给药设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、中东和非洲业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对疫苗给药设备市场的关注有关

疫苗接种设备市场的主要参与者包括：

• 美敦力（爱尔兰）
• Stening SRL（阿根廷）
• 库克（美国）
• 比卡克希拉尔医疗中心（伊斯坦布尔）
• TROGE MEDICAL GmbH（德国）
• 河南驼人医疗器械有限公司 (中国)
• Fisher & Paykel Healthcare Limited（新西兰）
• Medis Medical（英国）有限公司（英国）
• Pulmodyne, Inc.（美国）
• 富士系统（日本）
• DEAS SRL（意大利）
• Sterimed 集团 (印度)
• 康维特集团 (英国)
• Smiths Medical（英国）
• Andreas Fahl Medizintechnik – Vertrieb GmbH（德国）
• 波士顿医疗产品公司（美国）
• TRACOE medical GmbH（德国）
• Teleflex Incorporated（美国）
• 维利得医疗股份有限公司 (中国) 

SKU-55563